"Great to work with, is creative, is whip-smart, so you can trust that she will reach the right conclusions." - LMG Life Sciences
Cheryl Reicin's practice focuses on biotechnology, medical device, health information and other technology-based companies, and representation of private equity/venture capital funds and investment banks that fund such companies. She also represents academic medical centers and universities. Her practice centers on U.S., Canadian and Israeli entities.
Cheryl assists companies in formulating domestic and international growth strategies and in sourcing capital. She advises on venture and later-stage financings, IPOs, mergers and acquisitions, licensing transactions and joint ventures or alliances with strategic partners. She also coordinates domestic and international structuring, intellectual property planning and regulatory strategy.
Cheryl is also a Certified Licensing Professional of the Licensing Executive Society (LES), United States and Canada.
Best Lawyers' Best Lawyers in Canada—Leading lawyer in biotechnology law (2010-2017)
Law Business Research’s Who’s Who Legal Canada and New York—Leading lawyer in life sciences (2010-2016)
Canada’s Most Powerful Women: WXN Top 100 Award Winner, 2014
Women of Influence, 2013 and 2014—Canada’s Top 25 Women of Influence (No. 1 in Professional Services category)
Expert Guides' Women in Business Law Guide—Leading practitioner in life sciences (2014-2016)
LMG Life Sciences Star, 2014 and 2015
LMG Life Sciences, 2013—Finance & Transactional Lawyer of the Year
Best Lawyers in Canada, 2014—Biotechnology Law Lawyer of the Year
Law Business Research’s International Who’s Who of Life Sciences Lawyers—Leading U.S. lawyer in transactional law (2010-2014)
Law Business Research’s Who’s Who Legal: International Who’s Who of Business Lawyers—Leading lawyer in life sciences (2010-2014)
Intellectual Asset Management's IAM Patent 1000: The World's Leading IP Transactions —Leading lawyer globally (2012-2016)
Lexpert/Thomson Reuters Canada’s Canadian Legal Lexpert Directory 2013, 2014—Repeatedly recommended practitioner in biotechnology
Intellectual Asset Management's IAM Licensing 250: The World's Leading Patent and Technology Licensing Lawyers 2010 and 2011/12—Leading lawyer globally
Practical Law Company’s Which Lawyer? 2012—Leading lawyer in life sciences: corporate and commercial
Lexpert/Thomson Reuters Canada’s Canadian Legal Lexpert Directory 2012—Repeatedly recommended practitioner in biotechnology and technology transactions
Lexpert/Thomson Reuters Canada’s Canadian Legal Lexpert Directory 2011—Consistently recommended practitioner in biotechnology
Practical Law Company’s Which Lawyer? Yearbook 2010 and 2011—Highly recommended lawyer in life sciences: corporate and commercial
Lexpert/Thomson's Canadian Legal Directory 2008, 2009 and 2010—Repeatedly recommended practitioner in biotechnology
Lexpert/American Lawyer Media’s Guide to the Leading 500 Lawyers in Canada 2006—Leading practitioner in serving the corporate midmarket
What Can the Canadian Start-Up Industry Learn from the Israeli Start-Up Industry; Vice Versa?
Redefining Early Stage Investment (RESI) Roundtable